Aegerion CEO on Cholesterol Drug Lomitapide

Oct. 18 (Bloomberg) -- Marc Beer, chief executive officer of Aegerion Pharmaceuticals Inc., talks about the company's lomitapide drug to treat the most life-threatening forms of high cholesterol. A U.S. Food and Drug Administration panel supported the use of the drug. Beer speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
Euro’s April Rally Biggest in Five Years
37:30 - Bloomberg’s Yvonne Man reports on the latest stories moving the FX market on “First Up.” (Source: Bloomberg)
  • MGM China 1Q Sales Falls 33%
  • Cisco Names Chuck Robbins CEO: Bloomberg West (05/04)
  • China Welcomes Taiwan’s Aim to Join AIIB